BIO uses a series of financial tools designed to contribute to the expansion of existing organisations or to help companies to set up in business. These investments can be made in Euros or in US dollars but also in local currency, on a case by case basis.

New companies or those who wish to expand their activities or strengthen their financial base can benefit from BIO’s support in the form of a direct equity stake or via financial institutions. BIO always takes a minority stake, generally tied to a seat on the Board of Directors, meant to be ceded to other shareholders, third parties or on the financial market once the company has reached a sustainable maturity level.

BIO also uses quasi-equity (mezzanine, subordinated loans, convertible loans, etc.) to strengthen the financial resources of up and coming companies, without diluting the position of its shareholders.

BIO offers a broad range of direct medium and long term loans at both fixed and variable rates. Their term can vary between 3 and 10 years, with a grace period of 3 years maximum. 

BIO’s signature is a guarantee of solvability and facilitates the mobilisation of resources by private sector borrowers by guaranteeing certain obligations on their behalf. 

Finally, BIO provides grants for feasibility studies prior to an investment or technical assistance necessary for the success of a project. These amounts are non–refundable.